source Post navigation Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss – geneonline.com Georgia Southern researcher comes in first place with international winning proposal for insulin pump redesign – Grice Connect